We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+21.29%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$748M
AUM Growth
+$84.9M
Cap. Flow
+$14.1M
Cap. Flow %
1.89%
Top 10 Hldgs %
41.51%
Holding
82
New
26
Increased
17
Reduced
9
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 31.22%
2 Consumer Discretionary 15.53%
3 Technology 12.7%
4 Industrials 12.46%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOMD icon
26
Nomad Foods
NOMD
$1.65B
$11.3M 1.51%
552,317
-254,463
-32% -$4.89M
ICPT
27
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$11.2M 1.5%
+100,000
New +$10.9M
FLXN
28
DELISTED
Flexion Therapeutics, Inc.
FLXN
$11M 1.48%
884,018
+300,000
+51% +$4.01M
CCJ icon
29
Cameco
CCJ
$41.1B
$9.7M 1.3%
822,683
+32,483
+4% +$390K
EW icon
30
PUT
Edwards Lifesciences
EW
$51.2B
$9.57M 1.28%
+150,000
New +$8.56M
WSC icon
31
WillScot Mobile Mini Holdings
WSC
$4.81B
$8.94M 1.2%
806,476
+1,560
+0.2% +$16.2K
ASH icon
32
Ashland
ASH
$3.28B
$8.83M 1.18%
113,025
+316
+0.3% +$24.3K
ZBH icon
33
Zimmer Biomet
ZBH
$19B
$8.4M 1.12%
67,748
+798
+1% +$90.7K
AMLP icon
34
Alerian MLP ETF
AMLP
$12.8B
$8.16M 1.09%
162,712
+65,000
+67% +$3.19M
IONS icon
35
PUT
Ionis Pharmaceuticals
IONS
$9.01B
$8.12M 1.09%
+100,000
New +$6.45M
LSCC icon
36
Lattice Semiconductor
LSCC
$18.2B
$7.97M 1.07%
668,468
+52,988
+9% +$529K
IFRX icon
37
InflaRx
IFRX
$261M
$6.63M 0.89%
+175,414
New +$6.53M
ATNX
38
DELISTED
Athenex, Inc. Common Stock
ATNX
$6.59M 0.88%
26,915
+6,869
+34% +$1.67M
TROX icon
39
Tronox
TROX
$933M
$6.51M 0.87%
+495,195
New +$5.24M
KYNB
40
PUT
Kyntra Bio
KYNB
$28.3M
$5.43M 0.73%
+4,000
New +$5.42M
CARM
41
DELISTED
Carisma Therapeutics
CARM
$5.4M 0.72%
261,978
GEG icon
42
Great Elm Group
GEG
$67.7M
$5.38M 0.72%
1,267,030
BHVN
43
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$5.15M 0.69%
+100,000
New +$4.32M
RPD icon
44
Rapid7
RPD
$726M
$5.06M 0.68%
+100,000
New +$4.28M
DOCU
45
DocuSign
DOCU
$11B
$4.4M 0.59%
+84,864
New +$4.33M
DCPH
46
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4.29M 0.57%
+184,994
New +$4.84M
BOLD
47
DELISTED
Audentes Therapeutics, Inc
BOLD
$4.21M 0.56%
108,031
HRTX icon
48
CALL
Heron Therapeutics
HRTX
$95.5M
$3.67M 0.49%
+150,000
New +$3.93M
MTEM
49
DELISTED
Molecular Templates, Inc.
MTEM
$2.99M 0.4%
34,282
TMQ
50
Trilogy Metals
TMQ
$608M
$2.47M 0.33%
+1,004,135
New +$2.2M

Similar funds

Kingdon Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Kingdon Capital Management held 82 positions worth $748M, up 13% from $663M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Kingdon Capital Management's Q1 2019 filing shows 26 new, 17 increased, 9 reduced and 21 closed positions. Its largest new stake was Alphabet (Google) Class A: 590,920 shares worth $34.8M. The largest sale was Bunge Global, an estimated $36.6M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Kingdon Capital Management's largest Q1 2019 buy was Alphabet (Google) Class A: 590,920 shares worth $34.8M.
  • Kingdon Capital Management added most to Caesars Entertainment in Q1 2019, an estimated $16.7M increase.
  • Kingdon Capital Management's biggest Q1 2019 reduction was Salesforce, cutting an estimated $11.1M.
  • Kingdon Capital Management fully exited Bunge Global in Q1 2019, selling an estimated $36.6M.
  • Kingdon Capital Management's ten largest holdings make up 42% of its $748M portfolio in Q1 2019.
  • Kingdon Capital Management opened 26 new positions and closed 21 in Q1 2019.
  • Kingdon Capital Management's portfolio value rose 13% quarter-over-quarter to $748M.

Based on Kingdon Capital Management's 13F filing for Q1 2019, filed 14 May 2019.